National Institutes of Health
Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional)
Active
About This Grant
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) seeks research project (R01) grant applications describing projects that integrate imaging and fluid-based tumor monitoring (liquid biopsy) assays during cancer therapy in patients to determine the optimal use of those modalities in the characterization of therapy response and/or emergence of resistance.
Who Can Apply
Higher EducationSmall BusinessGovernmentNonprofitsOtherNonprofits (preferred)
Focus Areas
Additional Details
- CFDA / ALN Number
- 93.393
- Program Title
- Cancer Cause and Prevention Research
- Estimated Total Funding
- Up to $500K
- Source
- Grants.gov · View original listing
Similar Grants
U.S. Mission to Cote d Ivoire
Freedom250 in Côte d’Ivoire American Spaces
$10K – $19KDue June 15, 2026U.S. Mission to Argentina
Grant Administration for Binational Centers (BNCs) in Argentina
$57K – $57KDue June 15, 2026Small Business Administration
Manufacturing in America E2G Grant Initiative
$5M – $5MDue June 15, 2026Center for Medicare and Medicaid Services
Make America Healthy Again – Enhancing Lifestyle and Evaluating Value-based Approaches Through Evidence
Up to $3.3MDue in 7 days — May 15, 2026Centers for Disease Control and Prevention - ERA
Occupational Safety and Health Education and Research Centers (T42)
$4.5M – $9MDue October 26, 2028National Institutes of Health
Risk and Protective Factors of Family Health and Family Level Interventions (R01 Clinical Trial Optional)
Due May 8, 2027